JPRN-jRCT2080221620未知3 期
Phase3 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Double-blind, Parallel Group,Placebo-Controlled Study)
Taisho Pharmaceutical co., LTD0 个研究点目标入组 132 人开始时间: 2011年10月17日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 132
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Type 2 diabetes mellitus
- •- HbA1c 6.5% to 10.0%
排除标准
- •- Except type 2 diabetes mellitus.
- •- Having critical Heart Disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease.
研究者
相似试验
未知
Unknown
A Long-Term Clinical Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal DysfunctioType 2 Diabetes Mellitus with Renal DysfunctionJPRN-jRCT2080221504Taisho Pharmaceutical co., LTD150
未知
2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)Type 2 Diabetes MellitusJPRN-jRCT2080221156Taisho Pharmaceutical co., LTD275
未知
2 期
A Pharmacokinetic Study of TS-071 in Type 2 Diabetes Mellitus Patients With Renal DysfunctioType 2 diabetes mellitus with renal dysfunctionJPRN-jRCT2080221237Taisho Pharmaceutical co., LTD50
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
已完成
2 期
ate Phase II Study of TS-142 in Patients with InsomniaInsomnia DisorderJPRN-jRCT2080225269Taisho Pharmaceutical Co., Ltd.160